Impact of operator volume on overall major adverse cardiac events following direct coronary stent implantation versus stenting after predilatation

Author： IJsselmuiden Sander  

Publisher： Informa Healthcare

ISSN： 1471-1796

Source： International Journal of Cardiovascular Interventions, Vol.6, Iss.1, 2004-03, pp. : 5-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes

By IJsselmuiden AJJ   Tangelder GJ   Cotton JM   Vaijifdar B   Kiemeneij F   Slagboom T   Wieken R v/d   Serruys PW   Laarman GJ  

International Journal of Cardiovascular Interventions, Vol. 5, Iss. 3, 2003-07 ,pp. : 143-150

Informa Healthcare

Access to resources Recommend Favorite

Direct stenting with the Bx VELOCITY™ balloon-expandable stent mounted on the Raptor® rapid exchange delivery system versus predilatation in a European randomized Trial: the VELVET trial

By Serruys Patrick W   IJsselmuiden Sander   Hout Ben van   Vermeersch Paul   Bramucci Ezio   Legrand Victor   Pieper Michael   Antoniucci David   Gomes Ricardo Seabra   Macaya Carlos   Boekstegers Peter   Lindeboom Wietze  

International Journal of Cardiovascular Interventions, Vol. 5, Iss. 1, 2003-01 ,pp. : 17-26

Informa Healthcare

Access to resources Recommend Favorite

Coronary stent implantation without balloon predilatation: a single-center experience

By Kaluski Edo   Gurevich Yoseph   Hendler Alberto   Zyssman Itzhak   Cotter Gad   Peleg Eli   and Meir Reicher   Krakover Rikardo  

International Journal of Cardiovascular Interventions, Vol. 2, Iss. 4, 1999-01 ,pp. : 231-235

Informa Healthcare

Access to resources Recommend Favorite

Clinical Outcome after Successful Coronary Angioplasty: Impact of Intracoronary Stent Implantation

By Nilsson Johan B.   Eriksson Anders   Ramberg Carl-Johan   Eriksson Peter  

Scandinavian Cardiovascular Journal, Vol. 34, Iss. 2, 2000-05 ,pp. : 178-181

Informa Healthcare

Access to resources Recommend Favorite

Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9): Impact of PCSK9 on Major Adverse Cardiac and Cerebrovascular Events

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 14, Iss. 2, 2017-01 ,pp. : 94-100

Bentham Science Publishers

Access to resources Recommend Favorite